Literature DB >> 16984804

L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization.

Georgia A Kotzia1, Nikolaos E Labrou.   

Abstract

Bacterial L-asparaginases (L-ASNases) catalyze the conversion of L-asparagine to L-aspartate and ammonia. In the present work, we report the cloning and expression of L-asparaginase from Erwinia chrysanthemi 3937 (ErL-ASNase) in Escherichia coli BL21(DE3)pLysS. The enzyme was purified to homogeneity in a single-step procedure involving cation exchange chromatography on an S-Sepharose FF column. The enzymatic and structural properties of the recombinant enzyme were investigated and the kinetic parameters (K(m), k(cat)) for a number of substrates were determined. In addition, we found that the enzyme can be efficiently immobilized on epoxy-activated Sepharose CL-6B. The immobilized enzyme retains most of its activity (60%) and shows high stability at 4 degrees C. The approach offers the possibility of designing an ErL-ASNase bioreactor that can be operated over a long period of time with high efficiency, which can be used in leukaemia therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984804     DOI: 10.1016/j.jbiotec.2006.07.037

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  21 in total

Review 1.  What makes a good new therapeutic L-asparaginase?

Authors:  Angela Beckett; David Gervais
Journal:  World J Microbiol Biotechnol       Date:  2019-09-24       Impact factor: 3.312

2.  Identification of functional regions in the Rhodospirillum rubrum L-asparaginase by site-directed mutagenesis.

Authors:  M V Pokrovskaya; S S Aleksandrova; V S Pokrovsky; A V Veselovsky; D V Grishin; O Yu Abakumova; O V Podobed; A A Mishin; D D Zhdanov; N N Sokolov
Journal:  Mol Biotechnol       Date:  2015-03       Impact factor: 2.695

3.  Reduction of acrylamide level through blanching with treatment by an extremely thermostable L-asparaginase during French fries processing.

Authors:  Shaohua Zuo; Tao Zhang; Bo Jiang; Wanmeng Mu
Journal:  Extremophiles       Date:  2015-06-16       Impact factor: 2.395

4.  Functional and structural evaluation of the antileukaemic enzyme L-asparaginase II expressed at low temperature by different Escherichia coli strains.

Authors:  Werner Alfinito Feio de Moura; Leonardo Schultz; Carlos Alexandre Breyer; Ana Laura Pires de Oliveira; Carlos Abrunhosa Tairum; Gabriella Costa Fernandes; Marcos Hikari Toyama; Adalberto Pessoa-Jr; Gisele Monteiro; Marcos Antonio de Oliveira
Journal:  Biotechnol Lett       Date:  2020-07-07       Impact factor: 2.461

5.  Identification and Molecular Characterization of Genes Coding Pharmaceutically Important Enzymes from Halo-Thermo Tolerant Bacillus.

Authors:  Azam Safary; Rezvan Moniri; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  Adv Pharm Bull       Date:  2016-12-22

6.  Biochemical characterization of a novel L-Asparaginase with low glutaminase activity from Rhizomucor miehei and its application in food safety and leukemia treatment.

Authors:  Linhua Huang; Yu Liu; Yan Sun; Qiaojuan Yan; Zhengqiang Jiang
Journal:  Appl Environ Microbiol       Date:  2013-12-20       Impact factor: 4.792

7.  Bacillus sonorensis L. Asparaginase: Cloning, Expression in E. coli and Characterization.

Authors:  Nihal Aly; Amani El-Ahwany; Farid Shokry Ataya; Hesham Saeed
Journal:  Protein J       Date:  2020-10-26       Impact factor: 2.371

8.  Purification, characterization and kinetic properties of extracellular L-asparaginase produced by Cladosporium sp.

Authors:  N S Mohan Kumar; H K Manonmani
Journal:  World J Microbiol Biotechnol       Date:  2012-11-24       Impact factor: 3.312

Review 9.  Enzymes in Metabolic Anticancer Therapy.

Authors:  Maristella Maggi; Claudia Scotti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.

Authors:  Alejandro Huerta-Saquero; Zahaed Evangelista-Martínez; Angélica Moreno-Enriquez; Ernesto Perez-Rueda
Journal:  Bioengineered       Date:  2012-08-16       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.